Sulfasalazine therapy for juvenile rheumatoid arthritis

Journal of Rheumatology

Volumn 23, Issue 2, 1996, Pages 360-366

  Imundo, Lisa F ^a,b   Jacobs, Jerry C ^a  

^a Columbia University ^*  (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Arthritis therapy; Disease modifying agents; Juvenile rheumatoid arthritis; Second line agents; Sulfasalazine

Indexed keywords

ACETYLSALICYLIC ACID; AURANOFIN; HYDROXYCHLOROQUINE; INDOMETACIN; METHOTREXATE; NAPROXEN; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE; SULINDAC; TOLMETIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; JOINTS; MALE; PROSPECTIVE STUDIES; SULFASALAZINE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0029873552     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Svartz N. The treatment of rheumatic polyarthritis with acid Azo compounds. Rheumatism 1948;4:56-60.
2. Sinclair RJG, Duthie JJR: Salazopyrin in the treatment of rheumatoid arthritis. Ann Rheum Dis 1948;8:226-31.
3. McConkey B, Amos RS, Butler EP, Crockson RA, Crockson AP, Walsh L: Salazopyrin in rheumatoid arthritis. Agents Actions 1978;8:438-41
4. Dougados M, van der Linden S, Leirisalo-Repo M, et al: Sulfasalazine in the treatment of spondyloarthropathy: A randomized, multicenter, double-bund, placebo-controlled study Arthritis Rheum 1995;38:618-27.
5. Pinals RS, Kaplan SB, Lawson JG, Hepburn B: Sulfasalazine in rheumatoid arthritis. Arthritis Rheum 1986;29:1427-34.
6. Dougados M, Maetzel A, Mijiyama M, Amor B: Evaluation of sulfasalazine in treatment of spondyloarthropathies. Ann Rheum Dis 1992;51:955-8.
7. Pullar T, Hunter JA, Capell HA: Which component of sulfasalazine is active in rheumatoid arthritis? BMJ 1985;290:1535-8.
8. Stenson WF, Lobos E: Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest 1982;69:494-7.
9. Stenson WF, Lobos E: Inhibition of platelet thromboxane synthetase by sulfasalazine. Biochem Pharmacol 1983;32:2205-9.
10. Rhodes JM, Bartholamew TC, Jewel DP: Inhibition of leukocyte mobility by drugs used in ulcerative colitis. Gut 1981,22:642-7.
11. Symmons D, Salmon M, Garner C, Blann A, Farr M, Bacon PA: Sulfasalazine and lymphocyte function in rheumatoid arthritis (abstr). Br J Rheumatol 1987;(suppl 1)26:9.
12. Carlin G, Nyman AK, Gronberg A: Effect of sulfasalazine on cytokine production by mitogen-stimulated human T-cells (abstr). Arthritis Rheum 1994;(suppl)37:S383.
13. Gronberg A, Isaksson P, Smedegard G: Inhibitory effect of sulfasalazine on production of IL-1β, IL-6 and TNFα (abstr). Arthritis Rheum 1994;(suppl)37:S383.
14. Veys EM, Mielants H, Joos R, DeClerq L: Juvenile spondyloarthropathies in 1992. J Rheumatol 1993;(suppl 37) 20:19-25.
15. Kanerud L, Scheynius A, Hafstrom I: Evidence of a local intestinal immunoregulatory effect of sulfasalazine in rheumatoid arthritis. Arthritis Rheum 1994;37:1138-45.
16. Giannini EH, Barron KS, Spenser CH, et al: Auranofin therapy for juvenile rheumatoid arthritis: result of a five year open label extension trial. J Rheumatol 1991;18:1240-2.
17. Brewer EJ, Giannini EH, Kuzmina N, Alexseen L: Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. N Engl J Med 1986;314:1269-76.
18. Prieur AM, Puissan CH, Manigne P, Bordigoni P, Griscelli C: Evaluation of d-penicillamine in juvenile chronic arthritis: A double blind, multicenter study. Arthritis Rheum 1985;28:376-92.
19. Mulberg AE, Linz C, Bern E, Tucker L, Verhave M, Grand RJ: Identification of nonsteroidal antiinflammatory drug induced gastrointestinal injury in children with juvenile rheumatoid arthritis. J Pediatr 1993;122:647-9.
20. Gabriel CA, Levinson JE: Advanced drug therapy in juvenile rheumatoid arthritis. Arthritis Rheum 1990;33:587-9.
21. Weinblatt ME, Weissman BN, Holdsworth DE, Fraser PA, Maier AI, Falchuk KR- Longterm prospective study of methotrexate: 84 month update. Arthritis Rheum 1992;35:129-37.
22. Rose CD, Singsen BH, Eichenfeld AH, Goldsmith DP, Atreya BH: Safety and efficacy of methotrexate therapy for rheumatoid arthritis. J Pediatr 1990;117:653-9.
23. Wallace CA, Sherry DD, Mellin ED, Aiken RP: Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment. J Rheumatol 1993;20:118-22.
24. Williams HJ, Ward JR, Dahl SL, et al: A controlled trial comparing sulfasalazine, gold sodium thiomalate and placebo in rheumatoid arthritis. Arthritis Rheum 1988;31:702-13.
25. Hannonen P, Mottonen T, Hakola M, Oka M: Sulfasalazine in early rheumatoid arthritis. Arthritis Rheum 1993;36:1501-9.
26. Palmer RG, Eversden E, Farr M, Johnson AE: A one year randomized trial of Ridura and sulfasalazine in rheumatoid arthritis (abstr). Arthritis Rheum 1994;(suppl)37:S258.
27. Galindo-Rodriquez G, Avina-Zubicta A, Russel AS, Suarez-Almazor ME: Trends in the patterns of practice in the use of first second line therapy in rheumatoid arthritis (abstr). Arthritis Rheum 1994;(suppl)37:S229.
28. Brewer EJ, Bass J, Baum J, et al: Current proposed revision of JRA criteria. Arthritis Rheum 1977;20:195-9.
29. Jacobs JC: Juvenile rheumatoid arthritis. In. Downey JA, Low N, eds. The Child with Disabling Illness, Principals of Rehabilitation, 2nd ed. Philadelphia: Raven, 1982:3-27.
30. Rose CD, Doughty RA: Pharmacological management of juvenile rheumatoid arthritis. Drugs 1992;43:849-63.
31. Lovell DJ, Giannini EH, Brewer EJ: Time course of response to nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis. Arthritis Rheum 1984;27:1433-7.
32. O'Dell J, Haire C, Erikson N, et al: Triple DMARD therapy for rheumatoid arthritis: Efficacy (abstr). Arthritis Rheum 1994;(suppl)37-S295
33. Ansell BM, Hall JK, Loftus P, et al: A multicenter pilot study of sulphasalazine in juvenile chronic arthritis. Clin Exp Rheumatol 1991;9:201-3.
34. Hoza J, Havelka S, Kadelcova T, Némcova D: Sulfasalazine in the treatment of juvenile chronic arthritis. Rheumatol Int 1990;20:71-4.
35. Ozdogon H, Turune M, Deringol B, Yurdakul S, Yazici H: Sulphasalazine in the treatment of juvenile rheumatoid arthritis: A preliminary open trial. J Rheumatol 1986;13:124-5.
36. Joos R, Veys EM, Mielants H, Werveke SV, Goemaere S: Sulfasalazine treatment in juvenile chronic arthritis: An open study. J Rheumatol 1991,18:880 4.
37. Giannini EH, Cassidy JT, Brewer EJ, Shaikov A, Maximov A, Kuzmina N: Comparative efficacy and safety of advanced drug therapy of children with juvenile rheumatoid arthritis. Semin Arthritis Rheum 1993;23:34-46.
38. Kvien TK, Hoyeraal HM, Sandstad B: Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis; assessment of tolerance and efficacy in a single-centre 24 week double-blind parallel study. Scand J Rheumatol 1984;13:342-50.
39. Clegg DO, Reda DJ, Weisman MH, et al: Comparison of sultasalazine and placebo for the treatment of Reiter's syndrome (abstr). Arthritis Rheum 1994;,(suppl)37:S206.
40. Baum J, Alekseev LS, Brewer EJ, Dolgopolova AV, Mudholkar GS, Patel K: Juvenile rheumatoid arthritis: A comparison of patients from the USSR and USA. Arthritis Rheum 1980;23:977-84.
41. Farr M, Palmer RG, Bacon PA. Sulfasalazine in rheumatoid arthritis: Long term tolerability in 423 patients monitored for 2 to 15 years (abstr). Arthritis Rheum 1994;(suppl)37:S256.
42. Nielson OH: Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 1982;17:389-93.
43. Silverman ED, Miller JJ, Bernstein B, Shafai T: Consumption coagulopathy associated with systemic JRA. J Pediatr 1983;103:872-6
44. Cate RHT, Cats A: Toxicity of Sulfasalazine in systemic juvenile chronic arthritis. Clin Exp Rheumatol 1991;9:85-8.
45. Sherry DD, Wallace CA: Sulfasalazine toxicity in children with systemic onset juvenile rheumatoid arthritis (abstr) Arthritis Rheum 1991;(suppl)34:S153
46. Caspi D, Fuchs D, Yarow M: Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis. Ann Rheum Dis 1992;51:275-6.
47. Hayllar J, Smith T, Macpherson A, Price AB, Gumpel M, Bjarnason I: Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Arthritis Rheum 1994;37:1146-50
48. Biamason I, Havliar J, Mcpherson A, Prince A, Gumpel M: Effects of disease modifying agents on nonsteroidal antiinflammatory drug induced small intestinal inflammation and blood loss in rheumatoid arthritis (abstr). Arthritis Rheum 1994;(suppl)37:S257.
49. van der Heijde DM, van Riel PL, Nuver-Zwart IH, van der Putte LB: Sulfasalazine vs hydroxychloroquine in rheumatoid arthritis: 3 year follow up. Lancet 1990;335:539.
50. Garcia Rodriquez LA, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-72.